HUMAN PAPILLOMA VIRUS
Clinical trials for HUMAN PAPILLOMA VIRUS explained in plain language.
Never miss a new study
Get alerted when new HUMAN PAPILLOMA VIRUS trials appear
Sign up with your email to follow new studies for HUMAN PAPILLOMA VIRUS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Could 2 HPV vaccine doses be enough? new study says maybe.
⭐️ VACCINE ⭐️ CompletedThis study looked at whether 2 doses of the HPV vaccine (Gardasil 9) protect as well as the standard 3 doses in people aged 15 to 26. Researchers measured antibody levels against nine HPV types. The goal is to see if a simpler schedule could work, making vaccination easier and ch…
Matched conditions: HUMAN PAPILLOMA VIRUS
Phase: PHASE4 • Sponsor: The University of Texas Medical Branch, Galveston • Aim: ⭐️ VACCINE ⭐️
Last updated Jun 27, 2026 12:08 UTC
-
Could a vaccine shot into warts make them disappear?
Disease control CompletedThis small pilot study tested whether injecting the Gardasil 9 HPV vaccine directly into genital warts could reduce their size and number. Only 2 adults with at least 3 warts each took part. The goal was to see if this approach is safe and worth studying further.
Matched conditions: HUMAN PAPILLOMA VIRUS
Phase: PHASE1, PHASE2 • Sponsor: University of California, San Francisco • Aim: Disease control
Last updated Jun 27, 2026 07:52 UTC
-
New Self-Test could revolutionize cervical cancer screening
Diagnosis CompletedThis study tested a new way to screen for cervical cancer using samples women collect themselves at home. Researchers wanted to see if a test that looks at DNA changes in HPV could better identify who truly needs follow-up care. About 294 women participated, and the goal was to m…
Matched conditions: HUMAN PAPILLOMA VIRUS
Sponsor: George Washington University • Aim: Diagnosis
Last updated Jun 27, 2026 09:10 UTC
-
At-Home HPV test could revolutionize cervical cancer screening
Diagnosis CompletedThis study tested whether women can collect their own vaginal samples to detect HPV, the virus that causes cervical cancer. Researchers compared self-collected swabs to those taken by a doctor in 222 participants. The goal was to see if self-sampling is accurate and acceptable, w…
Matched conditions: HUMAN PAPILLOMA VIRUS
Phase: NA • Sponsor: Mayo Clinic • Aim: Diagnosis
Last updated Jun 27, 2026 08:09 UTC
-
At-Home HPV test kits could boost cervical cancer screening in Hard-to-Reach women
Prevention CompletedThis study tested whether offering a vaginal self-sampling kit directly to women aged 50-65 who had not had a cervical smear in over three years would increase screening participation. Women received a kit to use at home and mail to a lab for HPV testing. The goal was to see how …
Matched conditions: HUMAN PAPILLOMA VIRUS
Phase: NA • Sponsor: University Hospital, Montpellier • Aim: Prevention
Last updated Jun 27, 2026 12:23 UTC
-
Can better training boost HPV shots? study tests two methods
Prevention CompletedThis study looked at two ways to help doctors talk to families about the HPV vaccine. Some clinics got training from an outside expert, while others learned from a vaccine champion within their own health system. The goal was to see which approach led to more children ages 9-12 g…
Matched conditions: HUMAN PAPILLOMA VIRUS
Phase: NA • Sponsor: UNC Lineberger Comprehensive Cancer Center • Aim: Prevention
Last updated Jun 27, 2026 11:00 UTC
-
App aims to educate women on HPV and breast cancer
Knowledge-focused CompletedThis study tested whether a mobile app-based education program could improve women's understanding of HPV and their attitudes toward breast cancer screening. Seventy women aged 30-65 used the app and completed surveys before and after the program. The goal was to see if the app c…
Matched conditions: HUMAN PAPILLOMA VIRUS
Phase: NA • Sponsor: Ataturk University • Aim: Knowledge-focused
Last updated Jun 27, 2026 11:00 UTC
-
PrEP users at risk for anal HPV? new study takes a look.
Knowledge-focused CompletedThis study looked at how often anal high-risk HPV infection and abnormal anal cells occur in men who have sex with men (MSM) who use PrEP to prevent HIV. Researchers collected anal samples and survey data from 304 participants, including both HIV-negative men on PrEP and HIV-posi…
Matched conditions: HUMAN PAPILLOMA VIRUS
Phase: NA • Sponsor: Universitair Ziekenhuis Brussel • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:05 UTC
-
Massive study reveals real cancer risk for HPV-Positive women with mild pap smears
Knowledge-focused CompletedThis study followed over 46,000 women in the Netherlands who tested positive for HPV and had mild abnormal Pap results. Researchers tracked how many developed cervical cancer within five years. The goal was to see if these women could safely have fewer follow-up tests, making scr…
Matched conditions: HUMAN PAPILLOMA VIRUS
Sponsor: Gynaecologisch Oncologisch Centrum Zuid • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:01 UTC
-
HPV Vaccine's Long-Term power tested in rwandan women
Knowledge-focused CompletedThis completed study looked at how well the HPV vaccine protects against HPV infections over time in over 3,000 Rwandan women aged 18-28, some living with HIV and some without. Researchers collected blood, oral, and other samples to measure vaccine effectiveness and long-term ant…
Matched conditions: HUMAN PAPILLOMA VIRUS
Sponsor: Montefiore Medical Center • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:54 UTC